Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera. BDO’s First Brands Audit Painted Healthy Picture Months Before Collapse The …
Dow Jones Top Company Headlines at 9 PM ET: Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk | BDO’s …
view original post